99 related articles for article (PubMed ID: 7652497)
1. The pharmacokinetics of meropenem.
Drusano GL; Hutchison M
Scand J Infect Dis Suppl; 1995; 96():11-6. PubMed ID: 7652497
[TBL] [Abstract][Full Text] [Related]
2. Meropenem clinical pharmacokinetics.
Mouton JW; van den Anker JN
Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
[TBL] [Abstract][Full Text] [Related]
3. The disposition and metabolic fate of 14C-meropenem in man.
Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
5. An overview of the pharmacology of intravenously administered ciprofloxacin.
Drusano GL
Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients.
Moon YS; Chung KC; Gill MA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S249-55. PubMed ID: 9126700
[TBL] [Abstract][Full Text] [Related]
7. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
[TBL] [Abstract][Full Text] [Related]
8. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL
J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363
[TBL] [Abstract][Full Text] [Related]
9. Changing role of carbapenems in the treatment of lower respiratory tract infections.
Lode H; Hamacher J; Eller J; Schaberg T
Scand J Infect Dis Suppl; 1995; 96():17-23. PubMed ID: 7652498
[TBL] [Abstract][Full Text] [Related]
10. Meropenem, a new carbapenem antibiotic.
Fish DN; Singletary TJ
Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
[TBL] [Abstract][Full Text] [Related]
12. Laboratory data which differentiate meropenem and imipenem.
Edwards JR; Turner PJ
Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
[TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes.
Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314
[TBL] [Abstract][Full Text] [Related]
15. An overview of the pharmacology of imipenem/cilastatin.
Drusano GL
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
[TBL] [Abstract][Full Text] [Related]
16. Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem.
Shibayama T; Yamamura N; Matsushita Y; Tokui T; Hirota T; Ikeda T
Xenobiotica; 2006 Dec; 36(12):1273-87. PubMed ID: 17162472
[TBL] [Abstract][Full Text] [Related]
17. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Kuo BI; Fung CP; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
